Voices: Kuehn

Orphans with Many Parents

Apparently FDA’s Office of Orphan Products Development wants to keep its record year quiet

By Steven E. Kuehn
Mar 11, 2015

Isn’t it funny how sometimes you stumble on to something and it quietly astonishes you? I did recently while catching up on current events. One of my news feeds brought forth a headline that really caught my eye: “The 2014 Numbers Are In: FDA’s Orphan Drug Program Shatters Records.” I clicked on it and up came “FDA Law Blog” published by patent law firm Hyman, Phelps & McNamara. And I paused for a second. I’m not sure why I was surprised by the source. In retrospect suppose I was expecting a more mainstream industry media outlet, you know, like, ahem, PharmaManufacturing.com (if you haven’t visited lately, click on over, we’ve upgraded the whole place).

Read More